 Relation skin cancer HLA antigens renal-transplant recipients BACKGROUND Recipients renal allografts risk skin cancer recipients homozygous HLA antigens risk certain cancers donors antigens case-control study relation skin cancer renal-transplant recipients HLA homozygosity mismatching METHODS patients renal transplants squamous-cell carcinoma basal-cell carcinoma skin transplantation HLA homozygosity recipients HLA mismatching results recipients skin cancer relation skin cancer use immunosuppressive drugs separate case-control influence exposure sun keratotic skin lesions risk skin cancer RESULTS risk squamous-cell carcinoma recipients HLA-B antigens relative risks percent confidence interval percent confidence interval antigens mismatching HLA-A HLA-DR antigens effect risk squamous-cell carcinoma association mismatches HLA loci occurrence basal-cell carcinoma total doses azathioprine prednisone occurrence skin cancer HLA Exposure keratotic skin lesions skin cancer HLA Homozygosity HLA-DR frequent patients squamous-cell carcinoma relative risk percent confidence interval patients keratotic skin lesions relative risk percent confidence interval CONCLUSIONS HLA-B mismatching risk squamous-cell carcinoma renal-transplant recipients HLA-DR homozygosity indirect effect level immunosuppression findings exposure number keratotic skin lesions observation